<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Although treatment of <z:hpo ids='HP_0001297'>stroke</z:hpo> patients with mild <z:hpo ids='HP_0002045'>hypothermia</z:hpo> is a promising therapeutic approach, chemicals inducing prompt and safe reduction of body temperature are an unmet need </plain></SENT>
<SENT sid="1" pm="."><plain>We measured the effects of the transient receptor potential vanilloid-1 (TRPV1) <z:chebi fb="4" ids="48705">agonist</z:chebi> rinvanil on thermoregulation and ischemic brain injury in mice </plain></SENT>
<SENT sid="2" pm="."><plain>Intraperitoneal or intracerebroventricular injection of rinvanil induces mild <z:hpo ids='HP_0002045'>hypothermia</z:hpo> that is prevented by the receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> capsazepine </plain></SENT>
<SENT sid="3" pm="."><plain>Both intraischemic and postischemic treatments provide permanent neuroprotection in animals subjected to transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAo), an effect lost in mice artificially kept normothermic </plain></SENT>
<SENT sid="4" pm="."><plain>Data indicate that TRPV1 receptor <z:chebi fb="4" ids="48705">agonists</z:chebi> are promising candidates for hypothermic treatment of <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>